Skip to main content

Table 1 Clinical properties of the ovarian cancer patients used in the analysis (GEO datasets)

From: Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis

GEO ID

Reference

GEO platform

No. of tumor samples in dataset

No. of normal samples in dataset

Death event

Median overall survival (mon)

Serous/endometrioid/clear cell/mucinous/others

Grade(I/II/III)

Stage(1/2/3/4)

Debulk optimal(/out of)

Treatment contains platin(/out of)

Treatment contains Taxol (out of)

GSE18520 [22]

Mok SC et al. 2009

GPL570

53

10

41

21

53/0/0/0/0

0/0/53

late stagec

NA

NA

NA

GSE19829 [23]

Konstantinopoulos PA et al. 2010

GPL570

28

0

17

35

23/0/0/0/0

0/0/28

0/2/22/4

23/27

NA

NA

GSE23554 [24]

Marchion DC et al. 2011

GPL96

28

0

14

 

28/0/0/0/0

2/8/18

advancedc

13

28

NA

GSE26193 [25]

Mateescu B et al.2011

GPL570

107

0

31

36.2

79/8/6/8/6

7/33/67

20/11/59/17

NA

NA

NA

GSE27651 [26]

King ER et al. 2011

GPL570

35

6normal

8LMPa

NA

NA

35/0/0/0/0

13low22highb

NA

NA

NA

NA

GSE30161 [27]

Ferriss JS et al. 2012

GPL570

58

0

36

33.1

47/5/1/1/2

2/19/33

0/0/53/5

30/56

58/58

54/58

GSE32062 [28]

Yoshihara K et al.2012

GPL570

10

0

NA

NA

10/0/0/0/0

0/0/10

late stagec

NA

NA

NA

GSE40595 [29]

Yeung TL et al.2013

GPL570

63

14

NA

NA

63/0/0/0/0

0/0/63

NA

NA

NA

NA

GSE44104 [30]

Wu YH et al. 2014

GPL570

60

0

16

NA

28/11/12/9/0

NA

17/8/30/5

NA

NA

NA

GSE51373 [31]

Koti M et al.2013

GPL570

28

0

NA

NA

28/0/0/0/0

highb

0/5/19/3

NA

NA

NA

GSE54388 [32]

Yeung TL et al.2017

GPL570

16

6

NA

NA

16/0/0/0/0

highb

NA

NA

NA

NA

GSE63885 [33]

Lisowska KM et al. 2014

GPL570

101

0

66

36.3

73/12/9/0/7

0/10/51

0/2/64/11

NA

75/75

41/75

GSE65986 [34]

Uehara Y et al.2015

GPL570

55

0

6

NA

16/14/25/0/0

NA

30/5/11/9

NA

NA

NA

GSE9891 [35]

Tothill RW et al. 2008

GPL570

267

18LMPa

NA

NA

264/20/0/0/1

20/99/161

24/18/217/22

NA

NA

NA

  1. NA Data not available, /out of Total number of patients with available clinical data
  2. aLMP Low malignant potential tumors or borderline tumors
  3. bNo specific grade shown
  4. cNo specific stage shown